Kingboard Holdings Limited (0148.HK)
Sha Tin, HK
Kingboard Holdings Limited, an investment holding company founded in 1988 and headquartered in Sha Tin, Hong Kong, maintains a diversified business portfolio. Its core industrial activities involve the manufacturing and sale of laminates and printed circuit boards. The company also operates a significant chemical division, producing and distributing a broad array of chemical products such as methanol, benzene, glacial acetic acid, propylene, methyl tert-butyl ether, liquefied petroleum gas, phenol, acetone, bisphenol A, caustic soda, polyvinyl chloride, hydrochloric acid, liquefied chlorine, chlorinated wax, sodium sulfate, formalin, hydrogen peroxide, and tetrabromobisphenol. Additionally, Kingboard manufactures and supplies magnetic and glass fabric products. Beyond its manufacturing operations, the company is actively engaged in property investment and development, managing a portfolio that encompasses commercial, residential, and industrial real estate for rental and sale purposes. It also handles the refining and distribution of various chemicals. Kingboard's products are sold across global markets, including the People's Republic of China, Thailand, Japan, Korea, Singapore, Europe, and the United States. The company adopted its current name in July 2018, having previously been known as Kingboard Chemical Holdings Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.31% | +19.11% | +37.04% | +62.27% | +152.50% | +123.94% | +192.22% | +198.86% | +59.20% | +310.42% | +2,488.58% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Conglomerates: +6.1%+5.3% Q4'25: +13.2% (vs Q4'23)
-
EPS growth Conglomerates: +16.9%+169.4% ★ Q4'25: +168.9% (vs Q4'23)
-
FCF margin FCF growth · Conglomerates: +35.9%-2.3% Q4'25: +1.7% (vs Q4'23)
-
EBIT margin Conglomerates: +9.0%+9.2% ★ Q4'25: +7.4% (vs Q4'23)
-
ROIC Conglomerates: +4.7%+4.6% Q4'25: +7.7% (vs Q4'23)
-
Share dilution Conglomerates: +0.0%+0.2% Q4'25: +0.3% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Conglomerates: 1.28×3.51× Q4'25: 1.92× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
32.79B
est: 34.37B (-4.6%)
|
35.83B
est: 37.34B (-4.0%)
|
43.16B
est: 41.84B (+3.1%)
|
45.99B
est: 41.08B (+12.0%)
|
41.16B
est: 48.35B (-14.9%)
|
43.51B
est: 50.45B (-13.8%)
|
56.76B
est: 62.69B (-9.5%)
|
49.38B
est: 49.25B (+0.3%)
|
39.71B
est: 39.22B (+1.3%)
|
43.09B
est: 44.26B (-2.6%)
|
45.38B
est: 47.57B (-4.6%)
|
58.06B
57.10B – 59.02B
+22.0% YoY
|
67.49B
65.42B – 69.55B
+16.2% YoY
|
73.76B
71.98B – 75.53B
+9.3% YoY
|
| EBITDA |
4.31B
est: 7.08B (-39.2%)
|
6.39B
est: 7.69B (-17.0%)
|
9.03B
est: 8.62B (+4.7%)
|
9.77B
est: 8.46B (+15.4%)
|
7.85B
est: 9.96B (-21.2%)
|
10.01B
est: 10.39B (-3.7%)
|
17.54B
est: 12.92B (+35.8%)
|
8.91B
est: 10.15B (-12.2%)
|
5.90B
est: 8.08B (-27.0%)
|
6.99B
est: 8.35B (-16.3%)
|
6.50B
est: 8.98B (-27.6%)
|
10.96B
10.78B – 11.14B
+22.0% YoY
|
12.74B
12.35B – 13.13B
+16.2% YoY
|
13.92B
13.58B – 14.25B
+9.3% YoY
|
| EBIT |
2.09B
est: 5.66B (-63.1%)
|
4.43B
est: 6.15B (-27.9%)
|
7.27B
est: 6.89B (+5.4%)
|
7.14B
est: 6.77B (+5.5%)
|
5.73B
est: 7.97B (-28.1%)
|
8.32B
est: 8.31B (+0.1%)
|
15.59B
est: 10.33B (+50.9%)
|
7.02B
est: 8.11B (-13.5%)
|
3.91B
est: 6.46B (-39.5%)
|
5.05B
est: 6.41B (-21.2%)
|
4.18B
est: 6.89B (-39.4%)
|
8.42B
8.28B – 8.55B
+22.0% YoY
|
9.78B
9.48B – 10.08B
+16.2% YoY
|
10.69B
10.43B – 10.95B
+9.3% YoY
|
| Net Income |
1.65B
est: 1.68B (-2.0%)
|
5.03B
est: 5.19B (-3.1%)
|
5.59B
est: 5.57B (+0.5%)
|
6.08B
est: 4.53B (+34.1%)
|
3.09B
est: 3.55B (-12.8%)
|
4.70B
est: 4.16B (+13.1%)
|
10.78B
est: 9.18B (+17.4%)
|
3.66B
est: 5.10B (-28.3%)
|
2.06B
est: 3.60B (-42.7%)
|
1.63B
est: 2.34B (-30.4%)
|
4.40B
est: 3.75B (+17.3%)
|
5.40B
5.39B – 5.42B
+44.1% YoY
|
6.55B
5.97B – 7.13B
+21.2% YoY
|
7.44B
7.21B – 7.67B
+13.6% YoY
|
| SGA |
2.64B
est: 2.63B (+0.6%)
|
2.76B
est: 2.85B (-3.1%)
|
2.86B
est: 3.20B (-10.7%)
|
3.16B
est: 3.14B (+0.7%)
|
3.15B
est: 3.70B (-14.7%)
|
3.16B
est: 3.86B (-18.1%)
|
3.73B
est: 4.79B (-22.2%)
|
3.74B
est: 3.76B (-0.6%)
|
3.51B
est: 3.00B (+17.0%)
|
3.44B
est: 3.47B (-0.9%)
|
3.75B
est: 3.73B (+0.5%)
|
4.55B
4.48B – 4.63B
+22.0% YoY
|
5.29B
5.13B – 5.45B
+16.2% YoY
|
5.78B
5.65B – 5.92B
+9.3% YoY
|
| EPS |
1.61
est: 1.52 (+5.9%)
|
4.89
est: 4.68 (+4.5%)
|
5.36
est: 5.02 (+6.7%)
|
5.69
est: 4.09 (+39.2%)
|
2.85
est: 3.20 (-11.0%)
|
4.26
est: 3.75 (+13.5%)
|
9.73
est: 8.29 (+17.4%)
|
3.30
est: 4.60 (-28.3%)
|
1.86
est: 3.25 (-42.7%)
|
1.47
est: 2.11 (-30.3%)
|
3.97
est: 3.38 (+17.5%)
|
4.87
4.86 – 4.88
+44.1% YoY
|
5.90
5.38 – 6.42
+21.2% YoY
|
6.70
6.49 – 6.91
+13.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-28 | A | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-27 | A | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-26 | A | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-22 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-21 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-20 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-19 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-18 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-15 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-14 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-13 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-12 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-11 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-08 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-07 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-06 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-05 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-04 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-30 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-29 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-28 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-27 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-24 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-23 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-22 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-21 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-20 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-17 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-16 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-15 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 1/5 | 4/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kwok Wing Cheung | Co-Founder & Executive Chairman | 34M | male |
| Ka Shing Cheung | Executive Director | 18M | male |
| Kin Fan | Executive Director | 18M | female |
| Kwong Kwan Cheung | Executive Director | 18M | male |
| Wing Yiu Chang | Chief Executive, MD & Executive Director | 18M | male |
| Yin Sang | Head of Chemical Business Operations & Executive Director | 16M | male |
| Ka Leong Lo | Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 0148.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
